Skip to content

Study for the Clinical Rational Drug Use of Interferon a1b Therapy in Children with Chronic Hepatitis B

Study for the Clinical Rational Drug Use of Interferon a1b Therapy in Children with Chronic Hepatitis B

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900020668
Enrollment
Unknown
Registered
2019-01-12
Start date
2019-01-10
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hepatitis B

Interventions

Case series:No intervention

Sponsors

302 Hospital of the Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 16 Years

Inclusion criteria

Inclusion criteria: 1. The diagnostic criteria for chronic hepatitis B and the indications for IFN treatment in children are in line with the European 2013 ESPGHAN Guidelines for the Diagnosis and Treatment of Chronic Hepatitis B in Children; 2. patients who are about to accept or are undergoing IFN a1b; 3. 1 year old = age = 16 years old, male or female; 4. From the 3 months before the application of interferon therapy, no other antiviral drugs have been treated; 5. Agree to sign the Informed Consent Form (Children aged 1-6 years may be signed by the guardian; children between the ages of 7 and 11 are in principle signed by the child and the guardian; those over the age of 12 must be signed by the child and the guardian).

Exclusion criteria

Exclusion criteria: 1. Combined with HCV, HDV or HIV-infected persons; 2. Receiving other medical treatments that may affect the pharmacokinetics or pharmacodynamics of IFN; 3. Those who have major diseases such as serious heart or brain diseases; 4. Combined with mental abnormalities, such as dementia; 5. Merged with mentally ill persons; 6. The research doctor considered it inappropriate to participate in the study.

Design outcomes

Primary

MeasureTime frame
IFN a1b serum drug concentration;

Countries

China

Contacts

Public ContactJingfeng Bi

302 Hospital of the Chinese People's Liberation Army

123bjf@163.com+86 18911809369

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026